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Abstract
Background: Chloroquine (CQ)-resistant Plasmodium falciparum malaria has been a global health catastrophe, yet much
about the CQ resistance (CQR) mechanism remains unclear. Hallmarks of the CQR phenotype include reduced accumulation
of protonated CQ as a weak base in the digestive vacuole of the erythrocyte-stage parasite, and chemosensitization of CQ-
resistant (but not CQ-sensitive) P. falciparum by agents such as verapamil. Mutations in the P. falciparum CQR transporter
(PfCRT) confer CQR; particularly important among these mutations is the charge-loss substitution KRT at position 76.
Dictyostelium discoideum transformed with mutant PfCRT expresses key features of CQR including reduced drug
accumulation and verapamil chemosensitization.
Methodology and Findings: We describe the isolation and characterization of PfCRT-transformed, hematin-free vesicles
from D. discoideum cells. These vesicles permit assessments of drug accumulation, pH, and membrane potential that are
difficult or impossible with hematin-containing digestive vacuoles from P. falciparum-infected erythrocytes. Mutant PfCRT-
transformed D. discoideum vesicles show features of the CQR phenotype, and manipulations of vesicle membrane potential
by agents including ionophores produce large changes of CQ accumulation that are dissociated from vesicular pH. PfCRT in
its native or mutant form blunts the ability of valinomycin to reduce CQ accumulation in transformed vesicles and decreases
the ability of K
+ to reverse membrane potential hyperpolarization caused by valinomycin treatment.
Conclusion: Isolated vesicles from mutant-PfCRT-transformed D. discoideum exhibit features of the CQR phenotype,
consistent with evidence that the drug resistance mechanism operates at the P. falciparum digestive vacuole membrane in
malaria. Membrane potential apart from pH has a major effect on the PfCRT-mediated CQR phenotype of D. discoideum
vesicles. These results support a model of PfCRT as an electrochemical potential-driven transporter in the drug/metabolite
superfamily that (appropriately mutated) acts as a saturable simple carrier for the facilitated diffusion of protonated CQ.
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Introduction
The advent and spread of CQ-resistant Plasmodium falciparum
malaria marked a great global health catastrophe of the 20
th
century. Yet, even as effective replacements for CQ are sought in
pharmaceutical research, much about the CQR mechanism
remains unclear. Hallmarks of the CQR phenotype include
reduced CQ accumulation in the digestive vacuole (DV) of the
parasite [1,2] and chemosensitization of CQ-resistant but not CQ-
sensitive parasites by such agents as verapamil (VP), tricyclic
antidepressants, phenothiazines, antihistamines, primaquine and
various plant alkaloids [3–8]. At the genetic level, mutations in the
parasite-encoded P. falciparum CQR transporter (PfCRT) confer
CQR; particularly important among these mutations in naturally
resistant parasites is the charge-loss substitution KRT at position
76 [9,10]. PfCRT may be phosphorylated for trafficking [11],
spans the membrane of the DV with ten predicted transmembrane
domains [9] and is a member of the drug metabolite/transporter
(DMT) superfamily of electrochemical potential-driven transpor-
ters [12–14] (http://www.tcdb.org/browse.php). Evidence for the
importance of a charge change in substrate recognition by PfCRT
has been reinforced by the findings of point mutations K76N and
K76I in CQ-resistant parasites selected from the CQ-sensitive
Sudan line 106/1 [15]. Conversely, CQ-sensitive parasites with
novel positively-charged PfCRT mutations have been obtained
from CQ-resistant parasites by stepwise selection with the antiviral
agent amantadine or the antimalarial agent, quinine (QN) [16,17].
CQ is a lipophilic weak base with two basic ionization sites
reported to have pKa values of 10.4 and 8.1, respectively, at 37uC
[18]. Although the concentration of the unprotonated form of CQ
is calculated to be less than 0.01% at neutral pH, it has generally
been believed that the drug diffuses by this neutral form across
lipid bilayers of the cell into acidic compartments such as the DV,
where it can become trapped due to its greater protonation at
lower pH (Henderson-Hasselbalch equilibrium) [19–21]. Yet CQ
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DV, a level difficult to explain by weak base partitioning alone
[22]. An additional component of CQ accumulation has been
associated with the digestion of hemoglobin and release of toxic
ferriprotoporphyrin IX (FP IX) in the DV, where this otherwise
toxic compound is converted to hematin and detoxified by
crystallization into hemozoin [23]. Strong binding of CQ to
hematin interferes with hemozoin formation and contributes to the
high drug concentrations found in the DV of sensitive parasites
after CQ treatment [19,22].
CQ efflux from the DV of resistant parasites is thought to occur
by facilitated diffusion of protonated CQ down its electrochemical
gradient [24,25]. The mutated PfCRT has been proposed to
promote this efflux either as a voltage gated channel [26,27] or as
a simple carrier [28–30] that may have been converted from an
exchange-only to a net transporting function [31]. More recent
reports of temperature-dependent, saturable drug transport by
mutant PfCRT at clinically relevant CQ concentrations [25] and
of specific effects of different quinoline compounds, peptides and
amantadine on PfCRT function [30,32] have weighed in favor of
a carrier model. Carrier saturation may explain observations in
Guinea-Bissau that CQR can be overcome by high level CQ
administration in twice daily doses [33], and carrier-mediated
facilitated diffusion of protonated drug is consistent with evidence
that PfCRT mutations can give rise to a CQ-associated ‘‘H+ leak’’
from the P. falciparum DV [14,34,35].
Reports from several studies have concluded that the CQR
phenotype depends upon a transmembrane potential that is
normally positive in its gradient from the inside of the DV (Dy)
[26,27,30,36,37]. Consistent with these conclusions, use of the
mitochondrial protonophore FCCP or glucose starvation to
deplete this gradient produced comparable CQ accumulation in
CQ-resistant and CQ-sensitive parasites [26]. While some of these
findings have been taken to support a PfCRT channel, the carrier
hypothesis of facilitated diffusion remains an alternative and more
likely model in view of bioinformatic analyses and the saturation
and temperature-dependent kinetics noted above [24,38].
The capacity of hematin to bind CQ in the P. falciparum DV and
the fact that DVs are difficult to isolate in quantity from
parasitized erythrocytes have complicated biochemical character-
izations of PfCRT. A number of research groups have therefore
obtained functional information on wild-type and different mutant
forms of PfCRT expressed in heterologous systems including
Xenopus laevis oocytes, Dictyostelium discoideum, and Pichia pastoris and
Saccharomyces cerevisiae yeast [25,27,30,36,39–41]. PfCRT-trans-
formed D. discoideum cells, which contain large acidic vesicles and
can be readily manipulated under experimental conditions, were
shown to have features of the CQR phenotype including reduced
drug accumulation and VP reversal [41]. Here we describe further
characterization of the CQR phenotype in transformed D.
discoideum and report the isolation and characterization of acidic
vesicles from these cells. Our results show that CQ accumulation
in the acidic vesicles of D. discoideum responds to membrane
potential as well as pH changes. We discuss the implications of
these findings in the context of present understanding of PfCRT
and its function in CQ transport.
Materials and Methods
D. discoideum Lines, Culture and Quality Controls
Axenic D. discoideum cells (AX2) were cultivated at 20uC in D3-T
basic media (KD Medical, Columbia, MD, USA) and harvested
for experiments during exponential growth phase (2–3610
6 cells/
ml). Cells were transformed with plasmids pEXP4 to express full-
length PfCRT as described previously [41]. Banks of cryopre-
served master and working lines were established to assure the
quality and functionality of all cells used for experiments. PfCRT
expression and presence of the appropriate CQR phenotype were
confirmed by PCR detection, immunoblotting and drug uptake
assays for each master D. discoideum line, multiple samples of which
were cryopreserved in liquid nitrogen. Individual samples from the
master bank of D. discoideum lines were expanded periodically,
confirmed by immunoblotting and drug uptake assays, and stored
in working banks at 280uC. Cells from these 280uC banks were
thawed as needed and placed into culture to generate the required
populations for experiments. Before vesicle purification, drug
uptake assays were performed to confirm presence of the
appropriate CQR phenotype in each of these populations [41].
Isolation and Storage of PfCRT-enriched Acidic Vesicles
Exponential growth-phase cells were collected by centrifugation
at 5006g for 5 min at 4uC and washed with D3-T basic media.
Packed cells were resuspended in 5 vol vesicle preparation buffer
(20 mM HEPES/Tris pH 7.3, 1 mM dithiothreitol, 1 mM
MgCl2, 6 mM K2SO4, 6 mM NaCl, and 210 mM sucrose) and
held on ice for 5 min. The suspension was passed twice through
a 25-mm 5.0 mm polycarbonate filter membrane (Sigma-Aldrich,
St. Louis, MO, USA) and immediately centrifuged at 10006g for
5 min at 4uC to clear nuclei and unbroken cells. Pellets of the
cellular material were collected from the supernatant in four steps
of differential speed centrifugation at 4uC (20006g, 40006g, and
20,0006g each for 10 min, 100,0006g for 1 h). Protein concen-
trations of the resuspended pellets and the final supernatant were
determined using a standard Bradford assay (Bio-Rad, Hercules,
CA, USA) to ensure quantitative loading of each well prior to
standard SDS-PAGE and immunoblotting. Amounts containing
15 mg of total protein were loaded for each fraction. PfCRT was
detected using polyclonal anti-PfCRT-rabbit antiserum [9].
Fixation and preparation of samples for transmission electron
microscopy observation were performed by standard procedures
[9]. For vesicle preservation and storage, the pellets were snap-
frozen on dry ice and stored at –80uC. The quality and function of
vesicles from all preparations were routinely confirmed by CQ
uptake and protein quantification assays. At least three batches of
vesicles were prepared from each cell line to determine average
values and standard deviations in each experiment.
pH Measurements of Intact Cells and Acidic Vesicles
Exponential growth-phase cells were pelleted (5006g, 5 min)
and washed twice in 10 mM phosphate buffer pH 7.5 (PB). Cells
(1.1610
8/ml) were then incubated for 1 h in either PB or PB
supplemented with 80 mM VP, 2 mM carbonylcyanide-m-chlor-
ophenylhydrazone (CCCP), or 100 nM concanamycin A (CMA)
(all chemicals from Sigma-Aldrich). Cells (1.1610
7) were trans-
ferred to a 2.5-ml disposable cuvette (Sigma-Aldrich), which was
inserted into the magnetic-stirring mount of a fluorimeter (Photon
Technology International [PTI], Birmingham, NJ, USA). Photo-
multiplier settings were 16Gain mA/Volts, 0.05 time constant at
1100 Volts. Cells were kept in suspension by magnetic stirring.
Estimates of vesicular pH within cells were obtained from
fluorescence signals after the addition of 0.5 mM LysoSensor
DND-167 (Molecular Probes, Eugene, OR, USA), a weak base
with pH-dependent excitation and emission peaks of 375 and
425 nm, respectively. Data were collected and analyzed using
Felix32 software (PTI).
Vesicles were obtained from exponential growth-phase cells
incubated for 2 h in D3-T basic media containing 2 mg/ml
fluorescein isothiocyanate (FITC)-dextran (Sigma-Aldrich). The
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described above for the isolation of PfCRT-enriched acidic
vesicles. Vesicles equivalent to 300 mg total protein were
suspended in 2 ml of desired buffer (indicated in Results) and
incubated at 22uC with continuous monitoring for fluorescence
curves or until measurement of final fluorescence end point values
after 10 min. Ratios of emitted fluorescence at 518 nm after
exposure to 450 and 494 nm excitation were obtained and
compared with known ratios from dye calibration curves of the
fluorescence of 1 mg/ml FITC in buffers of different pH (100 mM
sodium acetate/acetic acid pH 4 to 5.6; 100 mM dibasic/
monobasic sodium phosphate and pH 6 to 7.6) [42,43]. Although
the accuracy of pH determinations from these ratios might be
altered by intravesicular conditions that are different from those of
the calibration buffers, the relative pH determinations from the
vesicles proved to be highly reproducible and they provided the
consistency necessary for the comparative purposes of the
experiments reported here.
[
3H]-Drug Measurements in D. discoideum Whole Cells
and Acidic Vesicles
[
3H]-CQ, [
3H]-QN and [
3H]-piperaquine (PPQ) were from
American Radiolabeled Chemicals, Inc. (St. Louis, MO). Drug
uptake assays with intact cells were performed in PB (10 mM
Na2HPO4,1 0m MK H 2PO4, pH 7.5) as previously described [41]
using 100 nM [
3H]-drug and, where indicated, 80 mM VP, 2 mM
CCCP, or 100 nM CMA. Drug uptake assays with isolated
PfCRT-enriched acidic vesicles were performed using vesicles
equivalent to 75 mg total protein. Stored frozen vesicles were
thawed at room temperature (RT) for 1 min and transferred to ice
for 4 min. For each drug uptake experiment, vesicles were
suspended in 250 ml vesicle suspension buffer (VSB; 20 mM
HEPES/Tris pH 7.3, 1 mM dithiothreitol, 1 mM MgCl2,1m M
ATP, 6 mM K2SO4, 6 mM NaCl, 210 mM sucrose and 10 mg/
ml bovine serum albumin for surface tension reduction). For some
experiments, VSB without ATP was used as indicated, and for
others the 6 mM K2SO4 and 6 mM NaCl of VSB were replaced
with 30 mM sucrose (minimum cation buffer; MCB; total sucrose
concentration 240 mM). In experiments designed for osmotic
shock, vesicles were suspended as indicated for 5 min in a modified
form of VSB containing only 100 mM sucrose (osmotic shock
buffer, OS). Isoosmolarity was then reestablished by adding an
equal volume of VSB containing 320 mM sucrose for an
additional 5 min. In experiments with valinomycin, nigericin, or
monensin (Sigma-Aldrich), vesicles in VSB were incubated with
2 mM concentrations of these compounds for 10 min at 22uC and
quickly transferred onto ice before centrifugation at 100,0006g for
2 min at 4uC (Optima TLX ultracentrifuge; Beckman-Coulter,
Fullerton, CA, USA). After removal of the supernatant by
aspiration, the pellets were solubilized by suspension in 50 mlo f
NCS-II tissue solubilizer (Amersham, Arlington Heights, IL, USA)
for 2 h or overnight at RT. The solubilized samples were snap-
frozen in their tubes on dry ice, and the bottoms of the tubes
containing samples were cut into 4-ml scintillation vials (Perki-
nElmer, Foster City, CA, USA). Ten ml of acetic acid and 3 ml of
LSC-cocktail (Ultima Gold AB; PerkinElmer) were added, and
[
3H] scintillation counts were obtained in a Wallac Trilux 1650
Beta scintillation counter (Perkin Elmer).
Determination of Cytoplasmic ATP Levels
D. discoideum cells (1.1610
8 cells/ml) were incubated in PB or
PB supplemented with 80 mM VP, 2 mM CCCP, or 100 nM
CMA for 1 h under standard culture conditions. ATP levels were
detected using a bioluminescent assay kit (Sigma-Aldrich). Briefly,
2610
8 cells were pelleted and processed as described for the
preparation of PfCRT-enriched vesicles. Centrifugation at
100,0006g for 1 h yielded supernatants containing membrane-
free cytoplasm. Aliquots of 100 ml were snap-frozen on dry ice and
stored at –80uC. For ATP analysis, supernatants containing
cytoplasm were rapidly thawed in a water bath at RT, transferred
to ice, and diluted 1000-fold in VSB. Dilute supernatants (100 ml)
were mixed with 100 ml 25-fold diluted ATP assay mix, incubated
at RT for 3 min, and then measured in a standard luminometer
(TD 20/20; Turner Design, Sunnyvale, CA, USA).
Membrane Potential Assessments
Vesicles equivalent to 150 mg protein were suspended in 2 ml
MCB buffer and transferred into a 2.5-ml disposable cuvette,
which was placed into the mount of the PTI fluorimeter.
Photomultiplier settings were as described for pH measurements.
Vesicles were kept in suspension by magnetic stirring for 50 s
before DiOC5(3) (Molecular Probes; 1 mM stock in 20 ml DMSO)
was added to a final concentration of 250 nM. Fluorescence
changes indicative of changes in membrane potential were
monitored at emission wavelength 509 nm following excitation
of 484 nm. Potassium chloride, ATP, or weak bases were added at
time points and concentrations as indicated in the text. Data
analysis was performed using Felix32 software (PTI).
Results
Effects of Weak Bases on the CQR Phenotype of
Transformed D. discoideum Cells
Previous trans stimulation studies showed that pre-equilibrating
P. falciparum-parasitized erythrocytes with unlabeled CQ in the mM
range could partially reverse the phenotype of reduced [
3H]-CQ
accumulation in CQ-resistant P. falciparum [28]. To test for
a comparable effect of pre-established vacuolar concentrations of
unlabeled CQ on the features of CQR transferred to D. discoideum,
we performed similar [
3H]-CQ accumulation experiments with
untransformed D. discoideum cells, cells transformed with wild-type
PfCRT (WT-CRT; from CQ-sensitive parasite HB3), and cells
transformed with a mutated form of PfCRT (SEA-CRT; from
CQ-resistant parasite Dd2) [41]. After these cells were pre-loaded
for 5 min with different concentrations of unlabeled CQ and then
exposed to 100 nM [
3H]-CQ for 10 min, accumulation of the
[
3H] labeled drug was determined as a measure of competition
between the CQ species for transport by PfCRT. Levels of [
3H]-
CQ accumulation showed a clear dependence on the concentra-
tion of unlabeled CQ (Figure 1A). In the absence of unlabeled CQ
(PB control), [
3H]-CQ accumulation was reduced ,70% in SEA-
CRT-transformed relative to untransformed D. discoideum, and
little or no difference of accumulation was observed between WT-
CRT-transformed and untransformed D. discoideum. SEA-CRT-
transformed cells showed increasing accumulations of [
3H]-CQ in
the presence of unlabeled drug concentrations up to about 10 mM,
where [
3H]-CQ accumulation in SEA-CRT-transformed cells
approached the accumulations seen in untransformed and WT-
CRT-transformed cells (Figure 1A). We also noted that [
3H]-CQ
accumulations in untransformed cells and in cells transformed with
WT-CRT were slightly increased in the presence of 0.25 and
0.5 mM CQ, but these decreased at concentrations above 1 mM.
At unlabeled CQ concentrations of 10 mM, 100 mM, and
1000 mM, the accumulations of [
3H]-CQ in SEA–CRT-trans-
formed, WT–CRT-transformed, and untransformed cells were
comparable to each other but, at these different concentrations,
averaged only ,66%, 50%, and 30% of the accumulation of
untransformed cells in PBS alone (Figure 1A). Although the higher
PfCRT Activity in Dictyostelium Vesicles
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accumulation differences between the SEA-CRT-transformed,
WT-CRT-transformed, and untransformed cells, these concentra-
tions of unlabeled CQ did not show the ability of VP to increase
[
3H]-CQ accumulation in all cell lines (Figure 1B) [41].
We also examined the effects of different concentrations of
ammonia on [
3H]-CQ accumulation in SEA-CRT-transformed
relative to WT-CRT-transformed and untransformed D. discoi-
deum. The weak base action of ammonia has been shown to
effectively neutralize the pH of acidic vesicles in D. discoideum [44].
While 10 mM ammonia had little effect on [
3H]-CQ accumulation
in our three D. discoideum lines, 100 mM ammonia eliminated
accumulation differences among these lines by increasing [
3H]-
CQ accumulation in SEA-CRT-transformed cells and decreasing
[
3H]-CQ accumulation in WT-CRT-transformed and untrans-
formed cells (Figure 1A). Exposure to 1000 mM ammonia further
decreased [
3H]-CQ accumulation in all three lines. These results
are consistent with a large effect of vesicular pH on SEA-CRT-
mediated CQ accumulation by the untransformed and trans-
formed D. discoideum cells.
The ability of CQ-resistant P. falciparum to reduce intracellular
CQ levels is sensitive to treatments that affect pH and proton
electrochemical gradients across the DV membrane. Treatment
with protonophores, for example, can raise CQ accumulation in
CQ-resistant–and lower it in CQ-sensitive–parasites [26]. We
examined the influence of agents that collapse proton gradients on
the CQ accumulation of SEA-CRT-transformed, WT-CRT-
transformed, and untransformed D. discoideum cells. Relative to
no agent in PB control buffer, VP and the protonophore CCCP
each increased CQ accumulation in all cells and proved similar in
their ability to equalize CQ accumulation in SEA-CRT-trans-
formed relative to untransformed and WT-CRT-transformed cells
(Figure 1B). The V-type ATPase inhibitor CMA likewise reversed
the reduced accumulation phenotype of SEA-CRT transformed
D. discoideum, although without the overall increased accumulation
levels observed with VP and CCCP.
Effects of CCCP, CMA, and VP on D. discoideum ATP
Levels
CCCP inhibits mitochondrial ATP production and depletes V-
type and other ATPases of substrate [45]. CMA is thought to act
more specifically as an inhibitor of V-type ATPases [46]. The
actions of VP are much less well understood, although we have
found that VP actions include neutralization of vesicle acidity in D.
discoideum (results below). To further explore the effects of these
agents, we determined the cytoplasmic ATP levels of our
untransformed and transformed D. discoideum lines after treatment
with CCCP, CMA, or VP. In agreement with the reported effects
of CCCP, we found that ATP was fully depleted from cells
exposed to this agent (Figure 1C). Cells treated with CMA
contained 40% less cytoplasmic ATP, and VP-treated (80 mM)
cells contained 20% less ATP. With each of these agents, our
results showed little or no difference between the ATP levels of
untransformed, WT-CRT-transformed, or SEA-CRT-trans-
formed cells.
Figure 1. Measures of [
3H]-CQ uptake, ATP levels, and vesicle pH in untransformed, SEA-CRT-, and WT-CRT-transformed
Dictyostelium discoideum whole cells. (A) Labeled drug uptake by D. discoideum cells in PB containing 100 nM [
3H]-CQ and various concentrations
of unlabeled CQ and ammonia. Cells were incubated in [
3H]-CQ for 10 min before determination of [
3H]-CQ uptake. (B) Effects of VP, the
protonophore CCCP, and the V-Type ATPase inhibitor CMA on [
3H]-CQ uptake. (C) Effects of VP, CCCP, and CMA on cytoplasmic ATP levels. (D–F)
Relative effects of VP, CCCP, and CMA on acidic compartment pH traced by 0.5 mM LysoSensor
TM Blue DND-167 probe (FC, fluorescence counts; y-axis
scales are the same for figures D–F). Slight decreases of fluorescence from cells in PB after 600 s may be due to lysosomal alkalinization from the
LysoSensor
TM Blue DND-167 probe. Concentrations of 80 mM VP, 2 mM CCCP, and 100 nM CMA were employed in the experiments. Error bars
indicate standard deviations from three independent measurements.
doi:10.1371/journal.pone.0039569.g001
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discoideum Cells
The effects of CCCP, CMA, and VP on [
3H]-CQ accumulation
led us to also examine the effects of these agents on vesicular pH in
untransformed, WT-CRT-transformed, and SEA-transformed D.
discoideum cells. For this purpose, we used LysoSensor
TM Blue
DND-167, a commercially available weak base that exhibits strong
fluorescence in acidic compartments [47]. In control experiments
with the untransformed cells, addition of the LysoSensor
TM probe
produced a steep increase of fluorescence over a period of 3 min,
indicative of rapid dye uptake by acidic vesicles (Figure 1D). CMA
dramatically slowed this increase of fluorescence, which gradually
approached a plateau after 15 min. This finding is consistent with
blocked D. discoideum V-type ATPase activity, compromised vesicle
acidification, and slowed dye uptake in the presence of CMA [48].
Little or no increase of LysoSensor
TM fluorescence was detected in
cells exposed to VP or CCCP, consistent with marked loss of
vesicular acidity with these agents (Figure 1D). Figure 1, E and F,
shows results from LysoSensor
TM Blue DND-167 uptake experi-
ments with SEA-CRT-transformed or WT-CRT-transformed
cells. The tracings from both of these transformed lines were
similar to those of untransformed cells.
The evidence for loss of vesicular acidity in VP- or CCCP-
treated cells, which nevertheless can accumulate greater amounts
of CQ than cells treated with CMA or control cells in PB
(Figure 1B), indicates that a factor other than vesicular pH has
a key role in CQ accumulation by D. discoideum cells.
Isolation of Acidic Vesicles from Untransformed and
PfCRT-transformed D. discoideum Cells
D. discoideum transformants express PfCRT on the membranes of
acidic vesicles that are formed downstream of the endocytosis
pathway [41]. In initial attempts to isolate these vesicles, we found
that concentrations of monovalent ions above 25 mM in the
preparation buffer led to aggregation and alkalinization of the
vesicles, which evidently swapped out their protons under these
conditions. Time-consuming density gradient purification attempts
with the isosmotic contrast agent iodixanol resulted in loss of
vesicle acidity and loss of the CQR phenotype (from SEA-CRT-
transformed vesicles), which we could not effectively restore with
ATP-containing buffers or pre-incubation in acidic buffers (data
not shown). We therefore developed a rapid differential centrifu-
gation procedure in a low ion-containing, osmotically balanced
sucrose buffer for isolation of the acidic vesicles. After lysis of the
D. discoideum cells through a 5.0-mm polycarbonate filter and
centrifugation of the lysate at 10006g to remove nuclei, subcellular
fractions were recovered from the lysates in steps of increasing
centrifugation. Pellets that were recovered at 2,0006g and then at
4,0006g contained relatively small amounts of PfCRT, whereas
the pellet recovered in the subsequent step of centrifugation at
20,0006g for 10 min showed high enrichment for PfCRT by
semiquantitative immunoblot analysis (fraction F5; Figure 2A).
Further centrifugation of the supernatant at 100,0006g recovered
only small amounts of additional material with bands of fragments
or artifact (Figure 2A; compare the bands from the untransformed
cell lysate pellets with those from the SEA-CRT- and WT-CRT-
transformed cell lysate pellets). The predominant segregation of
PfCRT with the 20,0006g pellet (fraction F5) and its absence from
the final supernatant fraction (fraction F7) is consistent with the
location of PfCRT in vesicular membranes. Although fraction F4
also showed a detectable PfCRT band, this signal was weaker than
that of the F5 band (comparison based on equivalent pellet protein
loading), and the F4 pellet carried a large amount of lysed cell
debris. Experiments with fraction F4 were therefore not pursued.
Signals from lower relative molecular weight bands than that of
the expressed PfCRT form (Mr ,48,000) were also detected in
lanes F4 and F5, suggesting the presence of some polypeptides
from PfCRT fragments. Electron microscopy of fraction F5
confirmed a high proportion of intact vesicles (Figure 2B); this
fraction was used for routine preparations and subsequent
experiments. Three batches of vesicles were routinely prepared
from each cell line for parallel experiments to obtain average
values and standard deviations.
Reduced Accumulation of CQ and QN but not of PPQ by
SEA-CRT-transformed Vesicles
To evaluate drug accumulation by isolated vesicles, we in-
cubated fraction F5 with [
3H]-CQ, [
3H]-QN or [
3H]-PPQ in VSB
with or without its component of 1 mM ATP. Vesicles from this
fraction were also snap-frozen on dry ice and then thawed to test
whether vesicles could be conveniently stored in sample tubes for
assays at later times.
Results of these experiments showed that SEA-CRT-trans-
formed vesicles accumulated 40–50% less [
3H]-CQ than did
corresponding samples of untransformed or WT-CRT-trans-
Figure 2. Identification of vesicles enriched for PfCRT and
levels of radiolabeled drug accumulation. (A) Semi-quantitative
immunoblot (WB) analysis of membrane fractions precipitated at
10006g (F2), 20006g (F3), 40006g (F4), 20,0006g (F5), and
100,0006g (F6). Top, middle, and bottom panels show results from
the isolated vesicles of untransformed, SEA-CRT-, and WT-CRT-
transformed cells. Fractions F1 and F7 represent samples of whole
cells and supernatant, respectively. (B) Electron micrograph of a sample
from F5. (C) Labeled drug uptake in F5 vesicles incubated for 10 min
with 100 nM [
3H]-CQ, [
3H]-QN, or [
3H]-PPQ in VSB with or without 1 mM
ATP. Histograms compare results with fresh (solid bars) and stored
frozen F/T vesicles (hashed bars) prepared from untransformed, SEA-
CRT-, and WT-CRT-transformed D. discoideum. Error bars indicate
standard deviations of measurements from three independent mea-
surements on samples from the F/T vesicle preparation.
doi:10.1371/journal.pone.0039569.g002
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with freshly isolated and frozen/thawed (F/T) samples of vesicles.
Inclusion of 1 mM ATP in the VSB generally increased the
absolute counts of [
3H]-CQ accumulation, particularly in F/T
vesicles. In VSB from which ATP was omitted, the accumulation
of [
3H]-CQ in F/T vesicles was on average about 55% of the
accumulation in freshly isolated vesicles from the same D.
discoideum cell line, whereas in VSB containing 1 mM ATP, the
accumulation in F/T vesicles was more than 75% of the
accumulation in freshly isolated vesicles (Figure 2C).
[
3H]-QN accumulation–although in all cases lower on an
absolute scale than [
3H]-CQ accumulation–was likewise reduced
by ,50% in SEA-CRT-transformed relative to untransformed or
WT-CRT-transformed vesicles (Figure 2D). [
3H]-QN accumula-
tion was usually higher in freshly isolated relative to F/T vesicles,
and slightly greater [
3H]-QN accumulation was detected in
presence of 1 mM ATP.
In contrast to the results with [
3H]-CQ and [
3H]-QN, the
relative accumulation of [
3H]-PPQ was not reduced in SEA-CRT-
transformed vesicles (Figure 2E), consistent with our earlier
observations on PfCRT-transformed D. discoideum whole cells
[41] and with the comparable activity of PPQ on CQ-resistant and
CQ-sensitive P. falciparum [49]. Accumulation levels of [
3H]-PPQ
(adjusted for specific activity) were 2- to 3-fold greater in fresh
relative to F/T vesicles and were increased on average ,15% by
the presence of 1 mM ATP.
Measures of pH in Freshly Isolated and Frozen-thawed
Vesicles
In previous work, Naude ´ et al. (2005) measured the signals from
fluorescent dextrans in D. discoideum endosomes and estimated that,
over the course of 1 h, vesicular pH values rose from ,4.9–5.1 to
5.4–5.7 for post-lysosomal endosomes. These measures were in
a more acidic range than previously reported values of 6.2–6.5
[50] but were nevertheless consistent with the transition of acidic
lysosomal vesicles to less acidic post-lysosomal vesicles. Naude ´ et al.
[41] also found that the measured increases in vesicular pH were
slightly less in the WT-CRT- and SEA-CRT-transformed lines
than in untransformed D. discoideum, with slightly more acidity
observed for the vesicles of SEA-CRT relative to WT-CRT
transformants. To compare pH values of vesicles from all three cell
lines, we incubated intact D. discoideum cells with FITC coupled to
dextran, which was taken up by endocytosis, and then isolated the
vesicles for fluorescence measurements. After measurements of
FITC fluorescence at 518 nm from excitations at 450 and
494 nm, we calculated the fluorescence ratios and estimated
vesicular pH by comparison to a standard curve [42,43]. These
calculations yielded internal pHs of 6.16–6.18 for freshly isolated
vesicles from untransformed, SEA-CRT-, and WT-CRT-trans-
formed cells in VSB (Table 1; standard VSB contains 1 mM ATP),
and more alkaline pH values of 6.48–6.50 in VSB without ATP.
F/T vesicles exhibited pH values of 6.58–6.67 in VSB, with
slightly more acidic values for the PfCRT-transformed than
untransformed vesicles, and pH values of 6.85–6.92 in VSB
without ATP (Table 1).
The lower accumulation of [
3H]-CQ in more alkaline F/T vs.
freshly isolated vesicles (Fig. 2C) is in line with the behavior of CQ
as a di-protic weak base in compartments of different pH. Note,
however, that the fractional reduction of [
3H]-CQ accumulation
in SEA-CRT- vs. WT-CRT-transformed or untransformed
vesicles was similar in the freshly isolated and F/T preparations
(Figure 2C). In addition, based on our average of pH 6.49 for fresh
vesicles and pH 6.88 for F/T vesicles, the theory of di-protic weak
base accumulation would predict an 83% reduction in accumu-
lation, much more than observed and again suggesting a major
influence of a factor other than pH in CQ accumulation.
Considering these observations and the advantage and efficien-
cy of F/T vesicle preparations for experimental studies, we
performed all further work on F/T vesicles, thus providing
consistent and reproducible conditions for comparisons and
evaluations.
Substantial reversal of the CQR Phenotype in Isolated
Vesicles by OS or MCB but only limited reversal by VP
In agreement with the CQR phenotype of intact SEA-CRT-
transformed D. discoideum cells (Figure 1B), isolated SEA-CRT-
transformed vesicles accumulated 40 – 45% less [
3H]-CQ than
untransformed or WT-CRT-transformed vesicles in the absence
or presence of 1 mM ATP (Figures 2C and 3A). Inclusion of VP,
however, had only a limited effect on [
3H]-CQ accumulation in
isolated vesicles relative to its effect on [
3H]-CQ accumulation in
whole cells: SEA-CRT-transformed vesicles in the presence of
80 mM VP exhibited just ,25% of the reversal effect that was
observed with SEA-CRT-transformed whole cells in 80 mMV P
(compare Figures 3A and 1B). CCCP did not reverse the CQR
phenotype in isolated vesicles (Figure 3A), consistent with the fact
that the action of CCCP is by the inhibition of mitochondrial ATP
production in whole cells (Figure 1B, C).
Although VP provided only limited reversal of the reduced
CQR accumulation phenotype of isolated SEA-CRT-transformed
vesicles, subjection of these vesicles to 10 min in OS (VSB
containing 100 mM sucrose instead of 210 mM sucrose) followed
by addition of an equal volume of VSB containing 320 mM
sucrose (achieving a final sucrose concentration of 210 mM)
increased their [
3H]-CQ accumulation to the levels of similarly-
treated untransformed and WT-CRT-transformed vesicles (OS,
Figure 3A). Substituting MCB for VSB likewise resulted in
complete reversal of the CQR phenotype (Figure 3A).
Failure of VP to equalize [
3H]-CQ accumulation in isolated
transformed vesicles as it does in intact D. discoideum cells suggested
that full VP reversal of the CQ resistance phenotype depends on
a vesicle property that is altered during the isolation process. To
explore this possibility, we isolated the vesicles from cells that had
been pre-incubated with [
3H]-CQ in the presence of 80 mM VP.
Results showed that such isolated vesicles from SEA-CRT-, WT-
CRT-transformed, and untransformed cells contained equivalent
amounts of [
3H]-CQ (Figure 3A; VP-C). Addition of cellular lysate
supernatants to isolated vesicle suspensions prior to their exposure
to [
3H]-CQ and VP did not improve their VP-reversal phenotype
(data not shown).
Effect of VP, CCCP, OS, and MCB on the pH of F/T vesicles
Although VP and CCCP effectively eliminated the proton
gradients across membranes of acidic vesicles in intact cells
(Figure 1, D–F), these agents produced relatively small effects on
isolated F/T vesicles in VSB, raising their pH to 6.73–6.84 from
6.58–6.67 (compare entries in Tables 1 and 2). In contrast, F/T
vesicles subjected to OS for 10 min yielded pH values of 7.47–7.54
(Table 2), about 0.2 pH unit more alkaline than the pH of OS
itself. The explanation for these high pH values is not clear. One
possibility is that restoration of vesicle ion concentrations after
osmotic shock involves exit of protons and consequent alkaliniza-
tion through cation/H
+ exchange systems. However these high
pH values might be explained, note that relative levels of CQ
accumulation in the alkalinized vesicles after osmotic shock were
not greatly different from those of F/T vesicles in VSB (except for
reversal of the reduced drug accumulation phenotype in SEA-
CRT-transformed vesicles) or from those of vesicles isolated from
PfCRT Activity in Dictyostelium Vesicles
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3H]-CQ in the presence of
80 mM VP (Figure 3A).
In contrast to vesicles exposed to OS, vesicles in a modified
buffer in which monovalent ions were replaced with an osmotically
equivalent amount of sucrose (MCB) remained slightly acidic at
pH values of 6.76–6.93 (Table 2). Despite the difference between
these pH values and the alkaline pH values of osmotically shocked
vesicles, [
3H]-CQ accumulation in the vesicles did not greatly
differ (Figure 3A), again indicating an important role for a factor
other than pH in the CQR phenotype.
Effects of Ammonia and Unlabeled CQ on [
3H]-CQ
Accumulation and Vesicle pH
As an additional evaluation of [
3H]-CQ accumulation after
treatments that alter vesicular pH, we exposed isolated F/T
vesicles to different concentrations of ammonia in VSB (Figure 3B,
left panel). In the presence of 0.1 mM ammonia, the CQR
phenotype of SEA-CRT-transformed vesicles was blunted from
50% to 35% reduced relative accumulation by the opposite effects
of an increase of [
3H]-CQ in SEA-CRT-transformed vesicles and
a relative decrease of [
3H]-CQ in untransformed and WT-CRT-
transformed vesicles. Increasing the ammonia concentration to 1
mM achieved further blunting of the CQR phenotype but it did
not equalize the [
3H]-CQ levels of SEA-CRT-transformed vesicles
to those of untransformed or WT-CRT-transformed vesicles
(Figure 3B, left panel). These results were in contrast to the full
equalization achieved with 100 mM ammonia in the different lines
of whole cells (Figure 1) but were consistent with the observation
that VP likewise had a limited effect on the CQR phenotype of
isolated vesicles (Figure 3A).
We also studied the effects of unlabeled (cold) CQ on [
3H]-CQ
accumulation by isolated vesicles. In these experiments (Figure 3B,
right panel), [
3H]-CQ was included in the suspension buffer with
various concentrations of unlabeled CQ. Results from these
experiments showed that unlabeled CQ blunted the CQR
phenotype with greater potency than ammonia: 1 mM unlabeled
CQ reduced [
3H]-CQ accumulation about as much as did 1 mM
ammonia. Higher concentrations of unlabeled CQ differentially
reduced [
3H]-CQ accumulation in SEA-CRT-transformed rela-
tive to untransformed and WT-CRT-transformed vesicles and, at
1 mM, caused similar levels of accumulation (Figure 3B, right
panel) due to a ,65% reduction of [
3H]-CQ accumulation in
SEA-CRT-transformed vesicles vs. ,80% reductions in un-
transformed and WT-CRT-transformed vesicles. In contrast to
its effect on whole cells (compare Figure 1A), unlabeled CQ did
not increase the accumulation of [
3H]-CQ in vesicles from SEA-
CRT-transformed cells at concentrations of 10 and 100 mM.
To estimate the pH values of vesicles under these experimental
conditions, we obtained continuous measures of fluorescence ratios
from F/T FITC-loaded vesicles in VSB as described for Table 1.
Table 1. Estimated pH of freshly isolated and F/T vesicles isolated from untransformed and PfCRT-transformed D. discoideum.
Preparation Untransformed AX2* SEA-CRT-transformed AX2 WT-CRT-transformed AX2
Fresh vesicles in VSB
{ 6.1860.003 6.1660.008 6.1860.004
Fresh vesicles in VSB w/o ATP 6.4860.007 6.4860.010 6.5060.004
F/T vesicles in VSB 6.6760.018 6.5860.014 6.5960.008
F/T vesicles in VSB w/o ATP 6.9260.078 6.8560.035 6.8660.050
*D. discoideum AX2 line.
{Standard VSB contains 1 mM ATP.
doi:10.1371/journal.pone.0039569.t001
Figure 3. Effects of buffer conditions on [
3H]-CQ accumulation
and pH in F/T vesicles from untransformed, SEA-CRT-, and WT-
CRT-transformed Dictyostelium discoideum. (A)[
3H]-CQ uptake by
F/T vesicles in VSB vs. vesicles exposed to 80 mM VP in VSB, 2 mM CCCP
in VSB, OS, or MCB. Levels in vesicles isolated from whole cells pre-
incubated in 100 nM [
3H]-CQ and 80 mM VP are shown at the right (VP-
C). (B) Radiolabel uptake by F/T vesicles exposed to 100 nM [
3H]-CQ in
VSB containing various concentrations of NH3 (0.0, 0.1 or 1 mM; left
panel) or various concentrations of additional unlabeled CQ (1, 10, 100
or 1000 mM; right panel). (C) pH determinations of isolated FITC-dextran
loaded vesicles incubated for 10 min in the presence of various
concentrations of CQ or 1 mM ammonia. Error bars indicate standard
deviations of measurements from three independent measurements on
samples from the F/T vesicle preparation.
doi:10.1371/journal.pone.0039569.g003
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change in these ratios, indicating an average pH 6.6–6.7 over
the 10-min measurement period (Figure 3C). However, significant
alkalinization was observed when the vesicles were exposed to
ammonia or unlabeled CQ. A 1 mM concentration of ammonia
immediately raised the vesicular pH to 6.9, which settled to 6.8
after 10 min (little change of pH occurred with 0.1 mM ammonia;
data not shown). In comparison to ammonia, added concentra-
tions of CQ affected vesicular pH more powerfully. For example,
0.1 mM CQ produced a rise from initial pH 6.6–6.7 to pH 7.1–
7.2, which settled to pH 7.0–7.1 after 10 min. A much greater
effect was observed after the addition of 1 mM CQ: endosomal
pH quickly rose to pH 7.9–8.1 before decreasing over 10 min to
pH 7.6–7.7 (Figure 3C).
Although 1 mM ammonia raised vesicular pH to a more
alkaline value than 10 mM CQ (Figure 3C), we note that [
3H]-CQ
accumulation was 50–100% greater in the presence of 1 mM
ammonia than in the presence of 10 mM unlabeled CQ
(Figure 3B). This was opposite of what would be expected if pH
alone were the major determinant of CQ accumulation. More-
over, the accumulation of [
3H]-CQ did not differ greatly in the
presence of 10 mM, 0.1 mM or 1 mM unlabeled CQ, despite the
large differences in the pH of vesicles exposed to these CQ
concentrations (compare Figure 3, B and C).
Effects of Ionophores on [
3H]-CQ Accumulation by Whole
Cells and Isolated Vesicles
Figure 4A compares [
3H]-CQ accumulation results from tests of
various ionophores on intact D. discoideum cells in PB and on F/T
vesicle preparations in VSB. Monensin is an electroneutral Na
+/
H
+-antiporter with little or no direct effect on membrane potential
[51]. In intact untransformed and WT-CRT-transformed D.
discoideum cells, monensin reduced CQ accumulation by approx-
imately 50%, whereas this drug showed no detectable effect on
[
3H]-CQ accumulation in SEA-CRT-transformed cells (Figure 4A,
left panel). Likewise, monensin treatment reduced [
3H]-CQ
accumulation more in untransformed and WT-CRT-transformed
F/T vesicles than in SEA-CRT-transformed vesicles (Figure 4A,
right panel). Consistent with the moderate reduction of [
3H]-CQ
accumulation in untransformed and WT-CRT-transformed ve-
sicles, monensin produced a moderate effect on vesicular pH only
(Table 3).
Nigericin, an electroneutral K
+/H
+-antiporter that also has little
or no direct effect on membrane potential [51], produced greater
reductions than monensin on [
3H]-CQ accumulation by un-
transformed and WT-CRT-transformed cells (Figure 4A, left
panel). Nigericin likewise produced greater reductions than
monensin of [
3H]-CQ accumulation in the isolated F/T vesicles
from transformed and untransformed cells (Figure 4A, right
panel), and it had a greater effect on vesicular pH, producing
a slightly alkaline condition (Table 3). In comparisons of [
3H]-CQ
accumulation by SEA-transformed vs. untransformed or WT-
CRT-transformed vesicles, only ,15–25% differences were found
for nigericin-treated vesicles whereas ,35–40% and ,45–50%
differences were found for monensin-treated and untreated
vesicles, respectively (Figure 4A, right panel).
Valinomycin, a K
+ ionophore that can produce strong effects on
membrane potential also caused marked reductions of [
3H]-CQ
accumulation in untransformed D. discoideum cells and isolated
vesicles; however, in contrast to the results with monensin and
nigericin, valinomycin reduced [
3H]-CQ accumulation in un-
transformed cells to a much greater extent than in WT-CRT or
SEA-CRT-transformed cells (Figure 4A, left panel). In isolated F/
T vesicles, valinomycin produced the greatest reductions of all the
ionophores, to low levels of [
3H]-CQ accumulation that were
similar in untransformed and SEA-CRT transformed vesicles, and
to a level in WT-CRT-transformed vesicles that was less than the
level seen in the corresponding nigericin-treated vesicles
(Figure 4A, right panel). Of particular note, a much greater effect
of valinomycin was evident on untransformed F/T vesicles relative
to F/T vesicles transformed with either WT-CRT or SEA-CRT.
Valinomycin moreover produced a change in the pH of un-
transformed vesicles that was opposite to the effect on vesicles from
PfCRT-transformed cells, i.e. exposure of valinomycin to the
PfCRT-transformed vesicles caused an acid shift to pH 6.53–6.54
whereas the valinomycin exposure to untransformed vesicles
shifted the pH upward to 6.9 (Table 3).
Effects of Valinomycin and K
+ on Vesicle Membrane
Potential
In light of the data indicating an important role of vesicle
membrane potential in the CQR phenotype [26,27,30,36,37], we
designed experiments to test for different membrane potential
responses of PfCRT-transformed vs. untransformed vesicles.
Membrane potential changes can be detected by real-time traces
of the fluorescent potential probe DiOC5(3) which accumulates
and forms voltage-dependent complexes in membranes, a process
that quenches the fluorescence of the monomers [52].
Isolated F/T vesicles suspended in VSB showed little or no
detectable change in DiOC5(3) traces after addition of 2 mM
valinomycin (data not shown); however, vesicles suspended in K
+-
free MCB all showed a marked enhancement of fluorescence
quenching after addition of 2 mM valinomycin (Figure 4B),
indicating increased negative membrane potential from the
valinomycin-induced efflux of vesicular K
+ ions out of F/T
vesicles. Subsequent addition of 25 mM K
+ to valinomycin-treated
vesicles in MCB reversed the additional component of DiOC5(3)
quenching by removing the negative electrochemical contribution
Table 2. Effect of VP, CCCP, OS, and high-sucrose MCB on pH of F/T vesicles isolated from untransformed and PfCRT-transformed
D. discoideum.
Preparation Untransformed AX2* SEA-CRT-transformed AX2 WT-CRT-transformed AX2
VSB
{ +100 mM VP 6.8260.082 6.8460.069 6.7760.025
VSB +2 mM CCCP 6.8360.049 6.7360.036 6.8360.032
OS 7.5460.040 7.4760.051 7.5160.005
MCB (240 mM sucrose)
{ 6.8060.180 6.9360.011 6.7660.023
*D. discoideum AX2 line.
{Standard VSB and MCB contain 1 mM ATP.
doi:10.1371/journal.pone.0039569.t002
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+ gradient across the valinomycin-
treated membrane (Figure 4B). Whereas this reversal of quenching
was complete with untransformed vesicles, it was not complete
with transformed either WT-CRT- or SEA-CRT-transformed
vesicles. These differences of reversal were quantified from each
trace by measurements of the fluorescence levels after (Figure 4B,
P3) and before (Figure 4B, P4) the addition of 25 mM K
+.I n
results from eight separate experiments, the WT-CRT- and SEA-
CRT-transformed vesicles showed , 55% of the K
+ step response
seen with untransformed vesicles in the presence of valinomycin
(Figure 4C). No significant differences in the additional polariza-
tion from valinomycin alone were detected among the traces of
untransformed, SEA-CRT-, or WT-CRT-transformed vesicles
(Figure 4C, P1–P2).
Discussion
In previous work, Naude ´ et al. [41] showed that D. discoideum
cells acquired the CQR phenotype of reduced CQ accumulation
when these cells were transformed with the mutant SEA but not
the WT form of PfCRT. Changes of intravesicular pH did not
account for these findings, implicating another factor in the
mechanism of reduced CQ accumulation by mutant PfCRT.
Moreover, this mechanism demonstrated structural specificity, as
reduction of CQ accumulation in D. discoideum transformants did
not extend to PPQ, a bisquinoline analog of CQ that is effective
against CQ-resistant parasites. Our present data confirm and
extend these observations of structural specificity of the PfCRT-
mediated mechanism and the involvement of a factor other than
pH on CQ accumulation by whole D. discoideum cells. The results
indicate that CQ accumulation in PfCRT-transformed vesicles
from D. discoideum cells is influenced by vesicle membrane
potential. These findings are consistent with the conclusions of
previous reports that: (1) the PfCRT-mediated CQR phenotype of
P. falciparum depends upon DV membrane potential
[26,27,30,36,37]; and (2) PfCRT, in its CQR form, operates as
a passive carrier under the influence of membrane potential or,
less likely, as a voltage-dependent channel through which pro-
tonated CQ can pass, allowing the diffusion of protonated CQ
down its electrochemical gradient and out of the DV [24–31].
Treatment of D. discoideum cells with VP or CCCP neutralized
the acid compartments of their vesicles while producing levels of
[
3H]-CQ accumulation above the level observed in untreated,
SEA-CRT-transformed cells (Figure 1B, D–F); [
3H]-CQ accumu-
lation in the VP- or CCCP-treated SEA-CRT-transformed cells
also showed little or no difference from the accumulation in
identically treated untransformed or WT-CRT-transformed cells.
pH dependence of the CQR phenotype is consistent with results
from PfCRT-transformed X. laevis oocytes, in which the reduced
accumulation phenotype conferred by PfCRT
CQR relative to
PfCRT
CQS was lost at pH ,7.4 and above [30]. It also explains
reversal of the CQR phenotype by accumulated levels of NH3 or
CQ as protonated weak bases (Figure 1A and 3B, C). The reason
for this overall increase of [
3H]-CQ accumulation in VP- and
CCCP-treated cells remains to be established (either transformed
or untransformed; Figure 1B). A possible explanation is that
endogenous transporters of the D. discoideum vesicles can act on
protonated CQ with different efficiencies at acidic or neutral pH.
Isolated vesicles showed only limited reversal of CQR pheno-
type in 80 mM VP even though the SEA-CRT-transformed D.
discoideum cells showed nearly complete reversal at this same
concentration of VP (compare Figures 3A and 1B). This limited
reversal likely relates to the effect of pH on the ability of VP, a weak
base, to accumulate and inhibit CQ efflux. As vesicles mature in
Figure 4. Influence of ionophores on [
3H]-CQ accumulation by
whole cells and isolated vesicles from untransformed and
PfCRT-transformed Dictyostelium discoideum. (A) Labeled drug
uptake by whole cells (in PB) or vesicles (in VSB) in the presence of
100 nM [
3H]-CQ and 2 mM concentrations of monensin (Mon), nigericin
(Nig), or valinomycin (Val). Cells were incubated in the buffers for
10 min before determination of [
3H]-CQ uptake. Note the similar
accumulations of [
3H]-CQ by untransformed and SEA-CRT-transformed
vesicles in the presence of Val. Error bars indicate standard deviations of
measurements from three independent measurements. (B) Represen-
tative DiOC5(3) fluorescence traces indicating membrane potential
changes in untransformed (black), SEA-CRT-transformed (grey), and WT-
CRT-transformed (light grey) F/T vesicles in MCB. Val (2 mM) was added
at 200 s, and K
+ (25 mM) was added at 300 s. P1, P2, P3, and P4 indicate
points where fluorescence intensity measurements were taken from the
tracings to determine the magnitude of hyperpolarization by valino-
mycin (P1, fluorescence level before valinomycin is added; P2, trough
fluorescence) and the magnitude of depolarization after addition of
25 mM K
+ (P3, peak fluorescence after K+ addition; P4, fluorescence
level before K
+ is added). FC, fluorescence counts. (C)A v e r a g e
valinomycin response (P1–P2) and recoveries of DiOC5 (3) fluorescence
(P3–P4) before and after addition of 25 mM K
+ in eight independent
experiments. Asterisks (*) indicate significant difference from the
average result with untransformed vesicles (P,0.005; n=8).
doi:10.1371/journal.pone.0039569.g004
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of an hour from an acidic lysosomal to a less acidic post-lysosomal
condition [53]. Presence of post-lysosomal vesicles in our
preparations would be consistent with the relatively high pH of
fresh isolated vesicles (pH ,6.5 without ATP) and the limited
ability of ATP in Mg
++-containing buffer to lower the pH of these
vesicles to more acidic levels (Table 1). VP presumably would not
have been able to accumulate in isolated SEA-CRT-transformed
vesicles to the levels necessary for full reversal of the reduced CQ
accumulation phenotype. This explanation is consistent with the
facts that VP reversal is firmly linked to PfCRT mutations in P.
falciparum [54,55] and that VP specifically inhibits the transport of
CQ by mutant forms of PfCRT expressed at the surface of X. laevis
oocytes [30].
CCCP fully reversed the CQR phenotype of intact SEA-CRT-
transformed D. discoideum cells but showed no such effect on
isolated vesicle preparations (compare Figure 1B and Figure 3A).
Notably, the reversal of the CQR phenotype of intact cells by
CCCP was achieved at a concentration (2 mM) that was about 50-
fold less than that required for complete reversal by VP or NH3
(80–100 mM). This large difference in concentration is explained
by the CCCP’s mechanism of action which inhibits mitochondrial
ATP production and thereby deprives the intracellular vesicles of
the energy they require for acidification (Figure 1B–F). Thus,
neutralization of the intracellular vesicles by CCCP was thus
achieved by a mechanism different from weak base lysosomotropic
action. Isolated vesicles treated with CCCP showed small if any
change in CQ levels, indicating little influence of this proto-
nophore on their accumulation phenotype (Figure 3A).
In contrast to the limited effects of VP and CCCP on isolated
vesicles, exposure of isolated vesicles to OS or to MCB with the
aim to perturb proton and other ion gradients across the vesicular
membrane successfully reversed the CQR phenotype (Figure 3A).
The intravesicular pH levels after these exposures were less acidic
in MCB (pH ,6.8–6.9, slightly higher than pH ,6.6–6.7 of F/T
vesicles in VSB) and alkalinized in OS (pH ,7.5) (Table 2). The
finding that MCB exposure reversed the CQR phenotype without
a large pH shift provides further evidence that conditions affecting
ion distributions and membrane potential are important determi-
nants of CQ accumulation and PfCRT activity in the vesicles.
To further explore the effects of ion distributions and
membrane potential in vesicles, we evaluated [
3H]-CQ accumu-
lation, vesicle pH and DiOC5(3) fluorescence in the presence of
the ionophores monensin, nigericin, and valinomycin. The
electroneutral transporters monensin (Na
+/H
+) and nigericin
(K
+/H
+) raised vesicle pH levels to ,6.8–6.9 and ,7.2–7.3,
respectively (Table 3). These treatments also caused marked
reductions of [
3H]-CQ accumulation in untransformed or WT-
CRT-transformed vesicles relative to comparatively minor reduc-
tions of [
3H]-CQ accumulation in SEA-CRT-transformed vesicles
(Figure 4A). In whole cells, the reductions of [
3H]-CQ accumu-
lation by monensin and nigericin were opposite to the effects of VP
and CCCP which increased [
3H]-CQ levels despite neutralization
of the vesicles (Figure 1B, D–F); these findings reinforce the case
for the roles of electrochemical gradients and additional endog-
enous transporters on [
3H]-CQ accumulation. Compared to
monensin-treated vesicles, nigericin-treated vesicles showed smal-
ler difference between the [
3H]-CQ accumulation of WT-CRT-
transformed vs. SEA-CRT-transformed or untransformed vesicles
(Figure 4A). As noted above for vesicles alkalinized by other
means, these smaller differences of [
3H]-CQ accumulation in
nigericin-treated vesicles at pH ,7.2–7.3 is consistent with the
results from PfCRT-transformed Xenopus oocytes, in which the
reduced accumulation phenotype conferred by PfCRT
CQR
relative to PfCRT
CQS was not evident at pH ,7.4 and above [30].
In experiments with the K
+ uniporter valinomycin, PfCRT in
both its native WT-CRT and mutant SEA-CRT forms blunted
the ability of valinomycin to reduce [
3H]-CQ accumulation in
transformed relative to untransformed vesicles (Figure 4A). The
near neutralization of untransformed vesicles (pH ,6.9; Table 3)
but not of PfCRT-transformed vesicles (pH ,6.5) in MCB
+25 mM K
+ may be explained by a PfCRT action that alters the
expression of endogenous channels or transporters involved in the
maintenance of pH and membrane potential. An alternative
explanation for these results could be that the effect of inward K
+
uniport through valinomycin is blunted in the transformed vesicles
by outward, PfCRT-mediated movement of K
+ in direct or
indirect exchange for protons, but for reasons discussed below this
possibility is unlikely. Different pH values between untransformed
and PfCRT-transformed vesicles were not observed after their
alkalinization by nigericin treatment, presumably because the
large, electroneutral K
+
(inward)/H
+
(outward) exchange from nigericin
was not affected by any activity of PfCRT.
Our findings from ionophore treatment, together with the
already existing evidence for effects of membrane potential on
PfCRT-mediated [
3H]-CQ accumulation [26,27,30,36,37], led us
to explore the influence of valinomycin and K
+ on DiOC5(3)
fluorescence from untransformed and PfCRT-transformed vesi-
cles. DiOC5(3) fluorescence quenching was rapid and indistin-
guishable between the untransformed and PfCRT-transformed
vesicles suspended in MCB (no K
+), indicative of an inside
negative membrane potential not altered by the presence of
PfCRT (Figure 4B). Treatment of these vesicles with valinomycin
exhibited increased membrane polarization (hyperpolarization)
because of valinomycin’s contribution of an additional outward-
directed flux of intravesicular K
+. This hyperpolarization could be
completely reversed by external K
+ (25 mM) only for untrans-
formed vesicles; little more than half of the hyperpolarization of
valinomycin-treated WT-CRT- or SEA-CRT-transformed vesi-
cles could be reversed by application of external K
+ (Figure 4B, C).
In experiments with Xenopus oocytes, Martin et al. [30] found that
the membrane potential of PfCRT-transformed oocytes was
Table 3. Effects of ionophores on pH of F/T vesicles isolated from untransformed and PfCRT-transformed D. discoideum.
Preparation Untransformed AX2* SEA-CRT-transformed AX2 WT-CRT-transformed AX2
VSB
{ +2 mM Monensin 6.8460.041 6.9360.027 6.8260.027
VSB +2 mM Nigericin 7.2760.029 7.2760.082 7.2460.054
MCB
{ +2 mM Valinomycin +25 mM K
+ 6.9060.012 6.5260.048 6.5460.094
*D. discoideum AX2 line.
{Standard VSB and MCB contain 1 mM ATP.
doi:10.1371/journal.pone.0039569.t003
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replacement of extracellular Na
+ by K
+, suggesting that decreased
expression of endogenous channels or transporters ensured the
maintenance of membrane potential in the presence of PfCRT.
Activation of endogenous transporters in Xenopus oocytes expres-
sing PfCRT has also been reported [40]. It is possible that the
effect of PfCRT on transformed D. discoideum vesicles was similarly
offset by altered expression of their endogenous membrane
proteins, resulting in no overall change of membrane potential
and reduced ability of external K
+ to reverse the effect of
valinomycin treatment. A less likely possibility for this reduced
ability of K
+ to reverse the valinomycin-induced hyperpolarization
of PfCRT-transformed vesicles might be that PfCRT transports
K
+ in symport or antiport with other substrates. However, we have
been unable to identify a precedent for such action on K
+ in the
DMT superfamily of proteins that share evolutionary affinity with
PfCRT and its orthologs [12,13]; known K
+ transporters and
channels reside in families other than those of the DMT
superfamily [56] (http://www.tcdb.org/).
Although genetic studies have established that mutations of
PfCRT are the central determinant of CQR in P. falciparum,a n
understanding of the native role of PfCRT has remained elusive
and the biophysical processes involved in resistance are yet to be
clarified. Further investigations of expressed PfCRT in vesicles and
model membrane systems should enable advances on several key
questions, among them: how electrochemical gradients and
membrane potential are linked to PfCRT-mediated reductions of
drug accumulation in the CQR phenotype; how VP interacts with
mutant PfCRT to reverse the CQR phenotype; and structure-
function relationships of PfCRT including a molecular description
of CQ binding in the mechanism of drug resistance.
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